Bioverse Labs

bioverselabs.com

Automating species identification using machine learning for AgTech and BioTech industries.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

THE LYNX GROUP ACQUIRES UPSTREAM PARTNERS TO CREATE A DYNAMIC DIVISION CATERING DIRECTLY TO THE PHARMACEUTICAL AND BIOTECH SPACE

The Lynx Group | August 14, 2020

news image

The Lynx Group (TLG) has acquired Upstream Partners in an effort to create a dynamic division catering directly to the pharmaceutical and biotech space. The ability to leverage the deep experiences and broad networks of both companies with external healthcare decision-makers and influencers together, allows the new division of TLG to provide pharmaceutical and biotech clients with thorough, market-informed perspectives needed throughout a product's life cycle. These insights are invaluable f...

Read More

MedTech

EVAXION BIOTECH IDENTIFIES GONORRHEA AS SECOND BACTERIAL PRODUCT TARGET

Evaxion Biotech | July 04, 2022

news image

The clinical-stage biotechnology company Evaxion Biotech A/S which specializes in the creation of AI-driven immunotherapies, said today that it has chosen gonorrhea as its second bacterial target for the Company's EVX-B2 vaccine product candidate. Evaxion has opted to create a preventative vaccination against Gonorrhea, a sexually transmitted disease (STD) that has fast acquired antibiotic resistance, as its second bacterial target. Based on preliminary results in pre-clinical...

Read More

Industrial Impact

SARTORIUS STEDIM BIOTECH TO ACQUIRE ALBUMEDIX, STRENGTHENING ITS PORTFOLIO OF INNOVATIVE ADVANCED THERAPY SOLUTIONS

Sartorius Stedim Biotech | August 09, 2022

news image

Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has agreed to acquire 100 percent of Albumedix Ltd. from private investors. The Nottingham, UK-based company provides best-in-class recombinant albumin-based solutions. Recombinant human albumin is an important component for the biopharmaceutical industry required for various applications, for example as an animal-free additive to cell culture media and for the stabilization of vaccines and viral therapi...

Read More

Industrial Impact

O2 INVESTS IN MODULAR DEVICES, INC.

O2 Investment Partners ( | January 24, 2022

news image

O2 Investment Partners announced that it has partnered with Modular Devices, Inc. and its President & CEO, Greg Mink, to support the Company’s continued growth. Terms of the deal were not disclosed. Founded in 1987, Modular Devices, Inc. is a leading provider of mobile and modular medical imaging equipment labs and cleanroom solutions throughout the United States. MDI’s medical imaging solutions offer various imaging modalities through short- and long-term leases t...

Read More
news image

THE LYNX GROUP ACQUIRES UPSTREAM PARTNERS TO CREATE A DYNAMIC DIVISION CATERING DIRECTLY TO THE PHARMACEUTICAL AND BIOTECH SPACE

The Lynx Group | August 14, 2020

The Lynx Group (TLG) has acquired Upstream Partners in an effort to create a dynamic division catering directly to the pharmaceutical and biotech space. The ability to leverage the deep experiences and broad networks of both companies with external healthcare decision-makers and influencers together, allows the new division of TLG to provide pharmaceutical and biotech clients with thorough, market-informed perspectives needed throughout a product's life cycle. These insights are invaluable f...

Read More
news image

MedTech

EVAXION BIOTECH IDENTIFIES GONORRHEA AS SECOND BACTERIAL PRODUCT TARGET

Evaxion Biotech | July 04, 2022

The clinical-stage biotechnology company Evaxion Biotech A/S which specializes in the creation of AI-driven immunotherapies, said today that it has chosen gonorrhea as its second bacterial target for the Company's EVX-B2 vaccine product candidate. Evaxion has opted to create a preventative vaccination against Gonorrhea, a sexually transmitted disease (STD) that has fast acquired antibiotic resistance, as its second bacterial target. Based on preliminary results in pre-clinical...

Read More
news image

Industrial Impact

SARTORIUS STEDIM BIOTECH TO ACQUIRE ALBUMEDIX, STRENGTHENING ITS PORTFOLIO OF INNOVATIVE ADVANCED THERAPY SOLUTIONS

Sartorius Stedim Biotech | August 09, 2022

Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has agreed to acquire 100 percent of Albumedix Ltd. from private investors. The Nottingham, UK-based company provides best-in-class recombinant albumin-based solutions. Recombinant human albumin is an important component for the biopharmaceutical industry required for various applications, for example as an animal-free additive to cell culture media and for the stabilization of vaccines and viral therapi...

Read More
news image

Industrial Impact

O2 INVESTS IN MODULAR DEVICES, INC.

O2 Investment Partners ( | January 24, 2022

O2 Investment Partners announced that it has partnered with Modular Devices, Inc. and its President & CEO, Greg Mink, to support the Company’s continued growth. Terms of the deal were not disclosed. Founded in 1987, Modular Devices, Inc. is a leading provider of mobile and modular medical imaging equipment labs and cleanroom solutions throughout the United States. MDI’s medical imaging solutions offer various imaging modalities through short- and long-term leases t...

Read More